# HCW Biologics Inc.: Form 8-K, filed Aug 14, 2026

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2026-08-14
- Accepted by EDGAR: Aug 14, 2026, 15:00 ET
- Period: 2026-08-10
- Accession: 0001493152-26-038240
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226038240/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000149315226038240/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000149315226038240/form8-k.htm

Filed Aug 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-038240. Last ingested by Listed: Nov 5, 2026, 12:33 ET. No prices; not investment advice.